SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 195 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6 | -14.3% | 314 | 0.0% | 0.00% | – |
| Q1 2024 | $7 | +40.0% | 314 | +29.8% | 0.00% | – |
| Q4 2023 | $5 | +25.0% | 242 | 0.0% | 0.00% | – |
| Q3 2023 | $4 | -20.0% | 242 | 0.0% | 0.00% | – |
| Q2 2023 | $5 | 0.0% | 242 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | -16.7% | 242 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | -99.8% | 242 | +44.9% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 167 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 167 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 167 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | +33.3% | 167 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | +50.0% | 167 | +79.6% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 93 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 93 | +20.8% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 77 | -43.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 135 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 135 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,168,691 | $30,297,000 | 13.16% |
| Boxer Capital, LLC | 234,220 | $3,272,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 296,310 | $4,139,000 | 0.70% |
| Ghost Tree Capital, LLC | 200,000 | $2,794,000 | 0.58% |
| Eventide Asset Management | 225,000 | $3,143,000 | 0.20% |
| Vident Investment Advisory, LLC | 103,558 | $1,447,000 | 0.12% |
| J. Goldman & Co LP | 147,181 | $2,056,000 | 0.11% |
| TIVERTON ASSET MANAGEMENT LLC | 137,732 | $1,924,000 | 0.10% |
| Crestline Management, LP | 55,368 | $773,000 | 0.10% |
| Tekla Capital Management LLC | 200,000 | $2,794,000 | 0.10% |